Colgate-Palmolive Company $CL Shares Purchased by Bayforest Capital Ltd

Bayforest Capital Ltd boosted its stake in Colgate-Palmolive Company (NYSE:CL) by 259.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,386 shares of the company’s stock after buying an additional 2,444 shares during the period. Bayforest Capital Ltd’s holdings in Colgate-Palmolive were worth $317,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in CL. Price T Rowe Associates Inc. MD increased its position in Colgate-Palmolive by 18.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock worth $3,186,651,000 after buying an additional 5,269,140 shares during the period. Nuveen LLC acquired a new stake in Colgate-Palmolive in the first quarter worth $217,593,000. Goldman Sachs Group Inc. increased its holdings in shares of Colgate-Palmolive by 34.5% during the first quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company’s stock valued at $747,762,000 after purchasing an additional 2,045,191 shares during the period. Diamond Hill Capital Management Inc. increased its holdings in shares of Colgate-Palmolive by 45.0% during the first quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company’s stock valued at $521,250,000 after purchasing an additional 1,727,105 shares during the period. Finally, GAMMA Investing LLC increased its holdings in shares of Colgate-Palmolive by 10,601.7% during the first quarter. GAMMA Investing LLC now owns 1,105,379 shares of the company’s stock valued at $103,574,000 after purchasing an additional 1,095,050 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

NYSE:CL opened at $83.22 on Thursday. The business’s 50-day moving average price is $86.27 and its 200 day moving average price is $89.65. The firm has a market cap of $67.26 billion, a P/E ratio of 23.38, a PEG ratio of 4.38 and a beta of 0.35. Colgate-Palmolive Company has a 52-week low of $82.29 and a 52-week high of $106.44. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. The firm had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.Colgate-Palmolive’s revenue was up 1.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.91 earnings per share. As a group, sell-side analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Analysts Set New Price Targets

CL has been the topic of a number of research analyst reports. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. UBS Group lowered their price target on Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a report on Thursday, July 17th. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $88.00 to $83.00 and set an “underweight” rating on the stock in a report on Monday, August 4th. Morgan Stanley lowered their price target on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Finally, Citigroup lowered their price target on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a report on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $98.00.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.